Anti-vascular endothelial growth factor dosing frequency and visual outcomes in macular oedema following branch retinal vein occlusion

por Modi, Yasha S., Goduni, Lediana, Moini, Hadi, Gibson, Andrea, Boucher, Nick, Lucas, Genevieve, Dhoot, Dilsher S.
Publicado 2023

Antivascular Endothelial Growth Factor Dosing Frequency and Visual Outcomes in Macular Edema Following Central Retinal Vein Occlusion

por Modi, Yasha S., Goduni, Lediana, Moini, Hadi, Gibson, Andrea, Boucher, Nick, Lucas, Genevieve, Dhoot, Dilsher S.
Publicado 2021

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD

por Avery, Robert L, Castellarin, Alessandro A, Steinle, Nathan C, Dhoot, Dilsher S, Pieramici, Dante Joseph, See, Robert, Couvillion, Stephen, Nasir, Ma'an A, Rabena, Melvin D, Le, Kha, Maia, Mauricio, Visich, Jennifer E
Publicado 2014

SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB

por Avery, Robert L., Castellarin, Alessandro A., Steinle, Nathan C., Dhoot, Dilsher S., Pieramici, Dante J., See, Robert, Couvillion, Stephen, Nasir, Ma'an A., Rabena, Melvin D., Maia, Mauricio, Van Everen, Sherri, Le, Kha, Hanley, William D.
Publicado 2017

A Phase I, Single Ascending Dose Study of GEM103 (Recombinant Human Complement Factor H) in Patients with Geographic Atrophy

por Khanani, Arshad M., Maturi, Raj K., Bagheri, Nika, Bakall, Benjamin, Boyer, David S., Couvillion, Stephen S., Dhoot, Dilsher S., Holekamp, Nancy M., Jamal, Karim N., Marcus, Dennis M., Pieramici, Dante, Aziz, Aamir A., Patki, Kiran C., Bridges, William Z., Barone, Samuel B.
Publicado 2022